DatEscalt Veröffentlicht am16:15 - 31. August 2024
priligy alternative PD 1 and CTLA 4 based inhibitory chimeric antigen receptors iCARs divert off target immunotherapy responses
priligy alternative PD 1 and CTLA 4 based inhibitory chimeric antigen receptors iCARs divert off target immunotherapy responses
1 Kommentar bisher